IL2 and cancer: Using a nine color flow cytometry panel, we similarly assessed whether the expression of IL-2/12 receptor subunits [CD25 (α), CD122 (β), CD132 (γ), and CD212 (β1)] could be detected in 13 healthy donors and 11 cancer patients (Table 2).